Therapeutic Uses
A form of choline called choline alfoscerate has shown promise for
Alzheimer's disease.
5
A substance related to choline called CDP-choline (or citicoline) may be slightly helpful for enhancing recovery from
strokes.
6
Slight evidence hints that lecithin or pure choline may be helpful for people with
bipolar disorder.
7,29
Lecithin has failed to prove effective for
tardive dyskinesia.
8,9
Lecithin has also failed to prove effective for improving
cholesterol profile
levels.
2,10
Some evidence suggests that individuals with
HIV
who are low in choline may experience more rapid disease progression.
11
However, there is no direct evidence that choline supplements offer any benefit for people with HIV.
Numerous studies have found that diets very low in choline lead to impaired liver function.
1,2,12-15
But these diets are contrived: One would have to work very hard to get so little choline in the diet! To what degree additional choline may benefit people with pre-existing liver damage is an area of ongoing research. In a
double-blind study
, use of phosphatidylcholine enhanced the effect of interferon in people with
chronic hepatitis
C, but not those with chronic hepatitis B.
16Open studies
have yielded mixed results.
17,18
Finally, there are theoretical reasons to believe that choline might have
cancer-preventive
properties. The notion stems from its function as a methyl donor. Methyl units are essential for RNA and DNA replication—a process ongoing in every cell of the body. The theory goes like this: Diets lacking sufficient methyl donors (such as choline) may cause an error in RNA or DNA synthesis, leading to a mutated gene and, hypothetically, to cancer initiation.
1,19
Indeed, in rats fed diets very low in choline and other methyl donors, cancer rates increased.
20,21
However, again it is a long step from the effects of an artificially low-choline diet to taking choline supplements.
Choline as phosphatidylcholine may reduce homocysteine levels.
30
This, in turn, might reduce heart disease risk, although the proposed homocysteine-heart disease connection remains far from proven. (See the
High Homocysteine
article for more information.)
References
1
Zeisel SH. Choline: an important nutrient in brain development, liver function and carcinogenesis.
J Am Coll Nutr. 1992;11:473-481.
2
Zeisel SH, Da Costa KA, Franklin PD, et al. Choline, an essential nutrient for humans.
FASEB J. 1991;5:2093-2098.
3
Jacob RA, Jenden DJ, Allman-Farinelli MA, et al. Folate nutriture alters choline status of women and men fed low choline diets.
J Nutr. 1999;129:712-717.
4
[No authors listed]. Choline: a conditionally essential nutrient for humans.
Nutr Rev. 1992;50:112-114.
5
De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial.
Clin Ther. 2003;25:178-193.
6
Davalos A, Castillo J, Alvarez-Sabin J, Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.
Stroke.
2002;33:2850-2857.
7
Cohen BM, Lipinski JF, Altesman RI, et al. Lecithin in the treatment of mania: double-blind, placebo-controlled trials.
Am J Psychiatry.
1982;139:1162-1164.
8
Gelenberg AJ, Dorer DJ, Wojcik JD, et al. A crossover study of lecithin treatment of tardive dyskinesia.
J Clin Psychiatry.
1990;51:149-153.
9
Domino EF, May WW, Demetriou S, et al. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy.
Biol Psychiatry.
1985;20:1189-1196.
10
Oosthuizen W, Vorster HH, Vermaak WJ, et al. Lecithin has no effect on serum lipoprotein, plasma fibrinogen and macro molecular protein complex levels in hyperlipidaemic men in a double-blind controlled study.
Eur J Clin Nutr. 1998;52:419-424.
11
Bogden JD, Kemp FW, Han S, et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection.
Am J Clin Nutr.
2000;72:809-815.
12
Misra S, Ahn C, Ament ME, et al. Plasma choline concentration in children requiring long-term home parenteral nutrition: a case control study.
JPEN J Parenter Enteral Nutr.
1999;23:305-308.
13
Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients.
Gastroenterology.
1992;102:1363-1370.
14
Tayek JA, Bistrian B, Sheard NF, et al. Abnormal liver function in malnourished patients receiving total parenteral nutrition: a prospective randomized study.
J Am Coll Nutr.
1990;9:76-83.
15
Burt ME, Hanin I, Brennan MF, et al. Choline deficiency associated with total parenteral nutrition.
Lancet. 1980;2:638-639.
16
Niederau C, Strohmeyer G, Heintges T, et al. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Hepatogastroenterology.
1998;45:797-804.
17
Guan R, Ho KY, Kang JY, et al. The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis.
Aliment Pharmacol Ther.
1995;9:699-703.
18
Chawla RK, Wolf DC, Kutner MH, et al. Choline may be an essential nutrient in malnourished patients with cirrhosis.
Gastroenterology.
1989;97:1514-1520.
19
Newberne PM. Lipotropic factors and oncogenesis.
Adv Exp Med Biol. 1986;206:223-251.
20
Wainfan E, Poirier LA. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression.
Cancer Res.
1992;52:S2071-S2077.
21
Rogers AE. Methyl donors in the diet and responses to chemical carcinogens.
Am J Clin Nutr.
1995;61:S659-S665.
22
Alvarez XA, Mouzo R, Pichel V, et al. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Methods Find Exp Clin Pharmacol.
1999;21:633-644.
23
Franco-Maside A, Caamano J, Gomez MJ, et al. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.
Methods Find Exp Clin Pharmacol.
1994;16:597-607.
24
Cacabelos R, Alvarez XA, Franco-Maside A, et al. Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia.
Ann N Y Acad Sci. 1993;695:321-323.
25
de la Morena E. Efficacy of CDP-choline in the treatment of senile alterations in memory.
Ann N Y Acad Sci.
1991;640:233-236.
26
Heyman A, Schmechel D, Wilkinson W, et al. Failure of long term high-dose lecithin to retard progression of early-onset Alzheimer's disease.
J Neural Transm Suppl.
1987;24:279-286.
27
Weintraub S, Mesulan MM, Auty R, et al. Lecithin in the treatment of Alzheimer's disease.
Arch Neurol.
1983;40:527-528.
28
Etienne P, Dastoor D, Gauthier S, et al. Alzheimer disease: lack of effect of lecithin treatment for 3 months.
Neurology.
1981;31:1552-1554.
29
Stoll AL, Sachs GS, Cohen BM, et al. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.
Biol Psychiatry.
1996;40:382-388.
30
Olthof MR, Brink EJ, Katan MB, et al. Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men.
Am J Clin Nutr.
2005;82:111-7.